HugoScore hugoscore.org

Ambient scribe

nVoq Voice

nVoq Voice gives clinicians control over dictation and ambient documentation. The capture guide includes a permission attestation and configurable retention, which qualify broader no-storage claims. Refusing recording is narrower than refusing all AI-assisted documentation.

AI-assisted draft Read full report Open directory

Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.

28 /100 toward patient-directed
Agency posture Mixed, institution-directed
The question we ask Who does nVoq Voice serve in this deployment?
Control Clinician-operated dictation and ambient documentation. Ambient recording refusal is narrower than refusal of all AI-assisted documentation.
Agency read Mixed, institution-directed
Vendor
nVoq Incorporated
Who it serves
Institutional, clinician-mediated clinical documentation AI
Primary User
Home health, hospice, palliative-care, and other post-acute clinicians; healthcare organizations and EHR technology partners are the buyers and administrators
Control Model
Professional or institution-configured service. Patient controls depend on the deployment.
Patient Impact
Clinician review can catch errors. The public materials do not give patients equivalent source access or a direct correction interface.
Profile Status
AI-assisted draft
Last assessed
Sep 8, 2026
Review Confidence
Moderate for current official workflow documentation (AI-assisted draft)
AI / Model
OpenAI Codex / GPT-6
Human Review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Summary judgment · 28 out of 100 toward patient-directed

Clinician-operated dictation and ambient documentation. Ambient recording refusal is narrower than refusal of all AI-assisted documentation.

Mixed, institution-directed

nVoq Voice gives clinicians control over dictation and ambient documentation. The capture guide includes a permission attestation and configurable retention, which qualify broader no-storage claims. Refusing recording is narrower than refusing all AI-assisted documentation.

Patient agency

How this tool changes agency

Expands agency when

Clinician review can catch errors. The public materials do not give patients equivalent source access or a direct correction interface.

Limits agency when

Actual consent, patient access, deletion propagation and non-recording alternatives remain deployment-specific

Patient agency assessment

Who sets and changes the goal?

Patient authority

Institutions choose configuration and clinicians control outputs. A documented recording refusal mechanism matters, but does not establish patient control of subsequent dictation or final wording.

What can the patient understand, question, or do?

Critical capacity

Clinician review can catch errors. The public materials do not give patients equivalent source access or a direct correction interface.

Can the patient evaluate the conditions of use?

Informed control

Retained product data must be distinguished from any zero-retention model-provider arrangement. Current guide evidence supports retaining this qualification.

Text findings

Conditions of use

Published controls and their limits

Retained product data must be distinguished from any zero-retention model-provider arrangement. Current guide evidence supports retaining this qualification.

What remains unknown?

Not tested or not established

Actual consent, patient access, deletion propagation and non-recording alternatives remain deployment-specific

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

Actual consent, patient access, deletion propagation and non-recording alternatives remain deployment-specific No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

AI-assisted draft · Moderate for current official workflow documentation (AI-assisted draft)